[ASND] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
31-Aug-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -37.40%
YoY- -149.71%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 444 372 1,043 1,169 1,136 1,258 1,977 -63.08%
PBT -30,743 -25,153 -16,426 -18,311 -13,359 -20,636 -12,249 84.78%
Tax -37 -14 22 -57 -74 -118 -254 -72.34%
NP -30,706 -25,139 -16,448 -18,254 -13,285 -20,518 -11,995 87.23%
Tax Rate - - - - - - - -
Total Cost 31,150 25,511 17,491 19,423 14,421 21,776 13,972 70.74%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -6,915.77 -6,757.80 -1,576.99 -1,561.51 -1,169.45 -1,631.00 -606.73 407.23%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.94 -0.78 -0.51 -0.72 -0.53 -0.82 -0.48 56.59%
EPS Diluted -0.94 -0.78 -0.51 -0.72 -0.53 -0.82 -0.48 56.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.